Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Treasury Shares (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Treasury Shares for 3 consecutive years, with $2.4 million as the latest value for Q1 2026.

  • Quarterly Treasury Shares fell 24.46% to $2.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Jan 2026, down 24.46% year-over-year, with the annual reading at $867963.0 for FY2024, N/A changed from the prior year.
  • Treasury Shares for Q1 2026 was $2.4 million at Kestra Medical Technologies, up from $2.2 million in the prior quarter.
  • The five-year high for Treasury Shares was $3.1 million in Q1 2025, with the low at $867963.0 in Q2 2024.
  • Average Treasury Shares over 3 years is $2.2 million, with a median of $2.3 million recorded in 2024.
  • Peak annual rise in Treasury Shares hit 47.78% in 2025, while the deepest fall reached 44.9% in 2025.
  • Over 3 years, Treasury Shares stood at $3.1 million in 2024, then dropped by 28.8% to $2.2 million in 2025, then grew by 6.8% to $2.4 million in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $2.4 million, $2.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.